| Polar Capital LLP | RV Sector Biotecnología | 24,04% | 13,54% | | | |
| Franklin Templeton International Services S.à r.l. | RV Sector Biotecnología | 23,64% | 4,71% | | | |
| Pictet Asset Management (Europe) SA | RV Sector Biotecnología | 21,53% | 3,14% | | | |
| Medical Strategy GmbH | RV Sector Biotecnología | 18,71% | 7,40% | | | |
| Candriam | RV Sector Biotecnología | 18,01% | 6,83% | | | |
| Welzia Management SGIIC | RV Sector Biotecnología | 17,94% | — | | | |
| UBS Asset Management (Europe) S.A. | RV Sector Biotecnología | 13,96% | 4,16% | | | |
| Janus Henderson Investors | RV Sector Biotecnología | 13,42% | 16,23% | | | |
| Sectoral Asset Management Inc | RV Sector Biotecnología | 12,07% | 2,91% | | | |
| Erste Asset Management GmbH | RV Sector Biotecnología | 10,88% | 3,17% | | | |
| DNB Asset Management SA | RV Sector Biotecnología | 6,53% | — | | | |
| JPMorgan Asset Management (Europe) S.à r.l. | RV Sector Biotecnología | 4,95% | -6,76% | | | |
| Andbank Wealth Management SGIIC | RV Sector Biotecnología | 0,29% | — | | | |
| Abante Asesores Gestión SGIIC | RV Sector Biotecnología | 0,28% | -4,61% | | | |
| DWS Investment GmbH | RV Sector Biotecnología | -1,76% | 3,13% | | | |
